Laura Gravelin, MD
Clinical Cardiac Electrophysiology · Grove City, OHNPI 1780868950
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (53.6%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 11 manufacturers reported payments, led by Medtronic at 59.6% of the total.
Across 208 payments — averaging $317.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$39K
- Boston Scientific$25K
- Biosense Webster, Inc.$806
- Philips North America LLC$328
- Abbott$176
- Novo Nordisk$141
- plus $129 from 5 others
Across 56 payments — averaging $12,286 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Medtronic$688K
What the payments were for
- Consulting fees$35,41954%
- Speaking & faculty fees$12,70019%
- Travel & lodging$10,15115%
- Food & beverage$7,86212%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 114 | $39,408 |
| Boston Scientific | 51 | $25,143 |
| Biosense Webster, Inc. | 25 | $806 |
| Philips North America LLC | 6 | $328 |
| Abbott | 3 | $176 |
| Novo Nordisk | 2 | $141 |
| Cardiva Medical, Inc. | 2 | $59 |
| Sanofi-aventis U.S. LLC | 1 | $30 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 2 | $22 |
| Pfizer | 1 | $12 |
| Altathera Pharmaceuticals LLC | 1 | $6 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GENERAL - THERAPIES$14,418
- EVERA MRI XT DR SURESCAN$941
- Arctic Front$548
- Claria MRI$326
- LINQ II$271
- Carto 3 System$238
- EMBLEM MRI S-ICD$238
- EMBLEM$217
- COBALT DR MRI SURESCAN$180
- CryoConsole$174
- WATCHMAN FLX$138
- Micra$134
- HeartMate 3 Left Ventricular Dev$132
- Carto 3$128
- (AO0) IGT Devices Intracardiac$124
- Watchman$121
- Wegovy$113
- Reveal LINQ$109
- RESONATE EL ICD VR$100
- Lasers$100
How this compares
$66,131 in reported general payments places this provider in the 85th percentile of 159 clinical cardiac electrophysiology providers in Ohio.
See all clinical cardiac electrophysiology providers in Ohio →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 449 | $482,509 |
| XareltoRivaroxaban | 89 | $107,591 |
| EntrestoSacubitril/Valsartan | 38 | $43,205 |
| FarxigaDapagliflozin Propanediol | 17 | $9,418 |
| Metoprolol Succinate | 321 | $4,418 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 107 | $4,033 |
| Flecainide Acetate | 54 | $2,800 |
| SotalolSotalol Hcl | 74 | $1,537 |
| Atorvastatin Calcium | 89 | $1,403 |
| Carvedilol | 138 | $1,331 |
| Losartan Potassium | 110 | $1,163 |
| Clonidine | 14 | $984 |
| Amiodarone Hcl | 37 | $793 |
| Nifedipine ErNifedipine | 25 | $695 |
| Potassium Chloride | 22 | $622 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $12 | $482,509449 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 159 clinical cardiac electrophysiology providers in Ohio.
Other clinical cardiac electrophysiology in Grove City
- Anish AminColumbus$1.1M
- Walid SalibaCleveland$511K
- Mohamed KanjBeachwood$442K
- John HummelColumbus$275K
- Bruce WilkoffCleveland$213K
- Alexandru CosteaCincinnati$188K
- Auroa BadinColumbus$188K
- Gaurang GandhiCincinnati$179K
- Ralph AugostiniColumbus$174K
- Dina SparanoMayfield Heights$147K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.